Trials / Completed
CompletedNCT00147628
Assessment Of Sildenafil On Erectile Function And Intercourse Satisfaction And To Validate A New Subject Questionnaire
A Multi-Center, Double-Blind Placebo Controlled, Flexible-Dose Study With An Open-Label Phase To Assess The Efficacy Of Sildenafil Citrate On Erectile Function And Intercourse Satisfaction As Well As To Validate The Sexual Experience Questionnaire And Its Treatment Responsiveness In Men With Erectile Dysfunction
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 209 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effectiveness of sildenafil on erectile function and intercourse satisfaction in men with ED as well as to validate the new Sexual Experience Questionnaire which incorporates functional and emotional elements of a man's sexual experience into one comprehensive questionnaire.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sildenafil citrate | |
| DRUG | placebo for sildenafil citrate |
Timeline
- Start date
- 2005-11-01
- Completion
- 2006-09-01
- First posted
- 2005-09-07
- Last updated
- 2021-02-01
Locations
20 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00147628. Inclusion in this directory is not an endorsement.